I received a $200.00 donation supporting Dolphins Challenge Cancer! dolphins.donordrive.com/index.cfm?fuse…

Online Now: Anti-PD-1 immunotherapy with androgen deprivation therapy induces robust immune infiltration in metastatic castration-sensitive prostate cancer dlvr.it/SyJRj4

#Genetic testing could be a game changer when it comes to #cancer testing and prevention. Learn from Sylvester #oncology experts Abdulrahman K. Sinno, Marijo Bilusic, MD, PhD and Carmen Calfa, MD how the #science is being used for the best patient outcomes. loom.ly/yeRHUaY

Articles in Press: Quantitative Analysis of Serial Positron Emission Tomography Imaging in Men with Metastatic Castration-resistant Prostate Cancer Treated with Enzalutamide buff.ly/47whz1k Marijo Bilusic, MD, PhD @aj_weisman Baris Turkbey MD Bill Dahut, MD @WilliamFigg1 Ravi A Madan M.D.

Where the magic ✨happens at Sylvester Comprehensive Cancer Center Experimental Therapeutics/Phase 1 Clinic this morning with Marijo Bilusic, MD, PhD Jaime Merchan #researchmatters -#lcsm

I received a $50.00 donation supporting Dolphins Challenge Cancer! dolphins.donordrive.com/index.cfm?fuse…

I received a $50.00 donation supporting Dolphins Challenge Cancer! dolphins.donordrive.com/index.cfm?fuse…

I received a $100.00 donation supporting Dolphins Challenge Cancer! dolphins.donordrive.com/index.cfm?fuse…

I received a $100.00 donation supporting Dolphins Challenge Cancer! dolphins.donordrive.com/index.cfm?fuse…

How does a cancer vaccine work? nature.com/articles/d4158…

We are hiring a postdoc. If you want to learn more/apply please visit careers.miami.edu/us/en/job/R100…

“Truqap combination (w/abiraterone) in #PTEN -deficient #mCSPC #ProstateCancer demonstrated statistically significant & clinically meaningful improvement in rPFS in #CAPItello-281 Phase III trial” Look forward to seeing this data & relative toxicity astrazeneca.com/media-centre/p…

Abs#45 @asco #GU25 Prelim data shows near term metastatic progression (conventional imaging) is a rare event in #PSMA+ #BCR #ProstateCancer Are we overtreating pts w/ median age of 70+ based on lack of understanding of #PSMA? This study continues… meetings.asco.org/abstracts-pres…

Hot off the press... Overcoming common emerging barriers to effective neoadjuvant immunotherapies: Expert Review of Anticancer Therapy: Vol 0 , No ja - Get Access tandfonline.com/doi/full/10.10…

#Metformin study reveals weight management benefits for ADT therapy. silke gillessen and Neeraj Agarwal, MD, FASCO discuss the results of the #STAMPEDE trial's metformin arm. The phase 3 trial evaluates the addition of metformin to ADT in patients with #mHSPC. #FullVideo on UroToday >

We had the honor of inviting Sylvester patient Donica Stephens to join us at the Miami Marlins Prostate Cancer Awareness Game. 🙌 Donica first met with Dr. Sanoj Punnen (sanoj punnen) at the Desai Sethi Urology Institute, part of UMiami Health System, and was later referred to Sylvester medical

Vitamin B12 for prophylaxis of capecitabine-associated hand–foot syndrome 💥Oral methylcobalamin reduced capecitabine-related HFS in HER2-negative early BC, with no added safety concerns 💬A simple prophylaxis option to support treatment adherence bmj.com/content/390/bm…

🔔Join us this morning at the virtual Sylvester Comprehensive Cancer Center 2025 #ClinicalTrialsCourse I will be speaking on importance of #communityengagement and addressing population needs when designing a trial. 🎯If your trial does not enroll the target population , it won’t succeed. 👉🏽Sign up

For those out there with less gray hair than me… Never underestimate the value in working with good people towards a common goal. You can always do more together Sometimes academia makes us forget that science is a team sport & no one does anything alone #ESMO25 ESMO - Eur. Oncology

National Cancer Institute's Working Group on Biochemically Recurrent Prostate Cancer: Clinical Trial Design Considerations National Cancer Institute #BCR #ProstateCancer #ClinicalTrial ascopubs.org/doi/10.1200/JC…